Literature DB >> 11241000

Normal standard curve for acoustic pharyngometry.

I Kamal1.   

Abstract

Pharyngeal size, compliance, and the dynamic behavior of the upper airway are important factors in the production of obstructive sleep apnea. Assessment of the upper airway for possible site(s) of obstruction is one of the keys to a successful management of the condition. Acoustic pharyngometry has the potential for localizing such sites, however, standardizing the operating technique and producing a standard normal curve is a prerequisite before exploring the potential of this equipment. A total number of 350 normal volunteers (271 males and 79 females) were examined by acoustic pharyngometry and a coefficient of variance of 5% to 7% was obtained from each of them. Mean and standard deviation of pharyngeal area at each point of X-axis (distance) was obtained and analyzed statistically to produce a general standard curve. Using special techniques during examination, the oropharyngeal junction and glottis were located, and thus a mapped acoustic pharyngogram was produced. Mean pharyngeal area was 3.194 cm(2) in males (SD 0.311) and 2.814 cm(2) in females (SD 0.331). Mean glottic area was 1.06 cm(2) in males (SD 0.119) and 0.936 cm(2) in females (SD 0.108). A minimal pharyngeal area is probably needed as a "golden standard" to evaluate patients with obstructive sleep apnea.

Entities:  

Mesh:

Year:  2001        PMID: 11241000     DOI: 10.1067/mhn.2001.113136

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  8 in total

1.  Upper airway size is related to obesity and body fat distribution in women.

Authors:  Luca Busetto; Elisa Calo'; Marco Mazza; Fabio De Stefano; Gabriella Costa; Valentina Negrin; Giuliano Enzi
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-07-29       Impact factor: 2.503

2.  Retro-nasal aroma release is correlated with variations in the in-mouth air cavity volume after empty deglutition.

Authors:  Anne Mishellany-Dutour; Alain Woda; Hélène Labouré; Pierre Bourdiol; Pauline Lachaze; Elisabeth Guichard; Gilles Feron
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

3.  Night-to-night variability in obstructive sleep apnea severity: relationship to overnight rostral fluid shift.

Authors:  Laura H White; Owen D Lyons; Azadeh Yadollahi; Clodagh M Ryan; T Douglas Bradley
Journal:  J Clin Sleep Med       Date:  2015-01-15       Impact factor: 4.062

4.  Acoustic pharyngometry measurement of minimal cross-sectional airway area is a significant independent predictor of moderate-to-severe obstructive sleep apnea.

Authors:  Pamela N Deyoung; Jessie P Bakker; Scott A Sands; Salma Batool-Anwar; James G Connolly; James P Butler; Atul Malhotra
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

5.  Alterations in upper airway cross-sectional area in response to lower body positive pressure in healthy subjects.

Authors:  Satomi Shiota; Clodagh M Ryan; Kuo-Liang Chiu; Pimon Ruttanaumpawan; James Haight; Michael Arzt; John S Floras; Christopher Chan; T Douglas Bradley
Journal:  Thorax       Date:  2007-04-18       Impact factor: 9.139

6.  A novel implantable device for a minimally invasive surgical treatment of obstructive sleep apnea: design and preclinical safety assessment.

Authors:  Edward Gillis; Charles Rampersaud; Emmanuelle Pease; Paul Buscemi
Journal:  Nat Sci Sleep       Date:  2016-07-20

7.  Combined application of pharyngeal volume and minimal cross-sectional area may be helpful in screening persons suspected of obstructive sleep apnea (OSA).

Authors:  Yuliang Zhao; Xinyu Li; Jiangang Ma
Journal:  Sleep Breath       Date:  2021-05-08       Impact factor: 2.816

8.  Acoustic pharyngometry: clinical and instrumental correlations in sleep disorders.

Authors:  Matteo Gelardi; Alessandro Maselli Del Giudice; Francesco Cariti; Michele Cassano; Aline Castelante Farras; Maria Luisa Fiorella; Pasquale Cassano
Journal:  Braz J Otorhinolaryngol       Date:  2007 Mar-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.